Filter
1250
Text search:
drug
regulation
Featured
88
353
Language
Document type
668
246
163
68
66
14
12
8
3
1
1
Countries
65
52
50
44
36
36
31
30
28
23
22
21
20
20
19
18
18
17
15
15
15
15
14
14
12
12
11
11
11
11
8
8
7
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
555
84
74
36
32
20
10
Toolboxes
153
124
80
71
44
34
33
28
22
19
19
18
14
13
12
12
11
11
7
6
5
3
3
1
Cocaine is a highly addictive and dangerous illicit substance that plague millions of Americans each year. Learn here about the dangers, warning signs, and how cocaine addiction can be treated.
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.
National Medicines Policy 2015
recommended
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
The purpose of these guidelines is to give practical advice to doctors so that all services and models of care used by doctors and health workers are encouraged to consider the use of telemedicine as a part of normal practice. These guidelines will assist the medical practitioner in pursuing a sound
...
A survey of prevention, testing and treatment policies and practices
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Prices people pay for medicines.
